Série anesthésique locale de matière première HCL de benzocaïne pour le tueur de douleur 23239-88-5
Abstrait
CAS:23239-88-5
MF:C9H11NO2.ClH
MW:201.65
Quality Standards Enterprise Standard/Pharma Grade
Appearance White powder
Catalog Local Anesthetics
Emballage:25kg/drum or as required
La description:
Benzocaine is also called amino ethyl benzoate, a colorless or white orthorhombic needle-like crystals or crystalline powder. Benzocaine hydrochloride salt is the hydrochloride salt form of the local anesthetic benzocaine, with the same pharmacological effects of benzocaine and weaker effect of anesthesia than procaine. Local absorption is slow with lasting effect. It cannot be used for anesthesia as a result of not being dissolved in water. It can be used for pain relief and anti-itch. Benzocaine hydrochloride is usually made into powder or oil paste and used to heal wounds, ulcers, burns, skin abrasions and hemorrhoids.
Application:
Benzocaines is an ester of paraaminobenzoic acid, lacking the terminal diethylamino group of procaine, with anesthetic activity. Benzocaine binds to the sodium channel and reversibly stabilizes the neuronal membrane which decreases its permeability to sodium ions. Depolarization of the neuronal membrane is inhibited, thereby blocking the initiation and conduction of nerve impulses.
Benzocaine hydrochloride salt is the hydrochloride salt form of the local anesthetic benzocaine, with the same pharmacological effects of benzocaine and weaker effect of anesthesia than procaine. Local absorption is slow with lasting effect. It cannot be used for anesthesia as a result of not being dissolved in water. It can be used for pain relief and anti-itch. Benzocaine hydrochloride is usually made into powder or oil paste and used to heal wounds, ulcers, burns, skin abrasions and hemorrhoids.Benzocaine hydrochloride readily dissolves in water and bezocaine is only very slightly soluable in cold water
certificat d'authenticité:
| Produit |
Benzocaïne |
| Essais |
Résultats |
Caractéristiques |
| La description |
Almost white powder |
Poudre blanche ou presque blanche |
| Solubilité |
Conforme |
Very soluble in alcohol and in acetone; légèrement soluble dans l'eau. |
| Identification |
Conforme |
By IR, to match with the working standard |
| Point de fusion |
37.5ºC~38.9ºC |
36ºC~39ºC |
| L'eau |
0.03% |
0,5 % |
| Résidu à l'allumage |
0.05% |
≤0.1% |
| Composé apparenté A |
Not detected |
≤0.01% |
| Related compounds |
Conforme |
pas plus de 0.2% of any individual impurity |
| Conforme |
not more than one impurity exceeds 0.1% |
| 0.13% |
pas plus de 0.5% of total impurities |
| Residual solvents |
Not detected |
Dichloromethane Not more than 0.06% |
| Not detected |
Ethanol Not more than0.5% |
| 0.04% |
Isopropyl ether Not more than0.5% |
| Essai |
99.67% |
99.0% (on the anhydrous basis) |
| Conclusion: Conforms to USP37 |
Grosses soldes
| Lidocaine hydrochloride |
73-78-9 |
|
| Benzocaïne |
94-09-7 |
|
| Chlorhydrate de benzocaïne |
23239-88-5 |
|
| Procaïne |
59-46-1 |
|
| Chlorhydrate de procaïne |
51-05-8 |
|
| Procaine penicillin G |
54-35-3 |
|
| Chloroprocaine hydrochloride |
3858-89-7 |
|
| Tétracaïne |
94-24-6 |
|
| Chlorhydrate de tétracaïne |
136-47-0 |
|
| Prilocaïne |
721-50-6 |
|
| Propitocaine hydrochloride |
1786-81-8 |
|
| Bupivacaine |
2180-92-9 |
|
| Bupivacaine hydrochloride |
14252-80-3 |
|
| Levobupivacaine |
27262-47-1 |
|
| Levobupivacaine hydrochloride |
27262-48-2 |
|
| Chlorhydrate de pramoxine |
637-58-1 |
|
| Ropivacaine |
84057-95-4 |
|
| Chlorhydrate de ropivacaïne |
132112-35-7 |
|
| Ropivacaine mesylate |
854056-07-8 |
|
| Chlorhydrate de proparacaïne |
5875-06-9 |
|
| Articaine |
23964-58-1 |
|
| Chlorhydrate d'articaïne |
23964-57-0 |
|
| Mepivacaine |
22801-44-1 |
|
| Cinchocaine(Dibucaine) |
85-79-0 |
|
| Mepivacaine hydrochloride |
1722-62-9 |
|
| Cinchocaine hydrochloride(Dibucaine HCL) |
61-12-1 |
|
| 2-(diethylamino)-N-(2,4,6trimethylphenyl)acetamide monohydrochloride |
1027-14-1 |
|
| Dimethocaine |
94-15-5 |
|
| Dimethocaine Hydrochloride |
553-63-9 |
|
| Chlorhydrate de procaïnamide |
614-39-1 |
Directeur commercial